Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
147.01B
Market cap147.01B
Price-Earnings ratio
44.93
Price-Earnings ratio44.93
Dividend yield
0.90%
Dividend yield0.90%
Average volume
2.27M
Average volume2.27M
High today
$376.95
High today$376.95
Low today
$368.90
Low today$368.90
Open price
$374.09
Open price$374.09
Volume
1.49M
Volume1.49M
52 Week high
$404.87
52 Week high$404.87
52 Week low
$329.16
52 Week low$329.16

Stock Snapshot

With a market cap of 147.01B, Stryker(SYK) trades at $372.00. The stock has a price-to-earnings ratio of 44.93 and currently yields dividends of 90.1%.

During the trading session on 2026-02-19, Stryker(SYK) shares reached a daily high of $376.95 and a low of $368.90. At a current price of $372.00, the stock is +0.8% higher than the low and still -1.3% under the high.

Trading activity shows a volume of 1.49M, compared to an average daily volume of 2.27M.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

SYK News

Simply Wall St 4d
Assessing Stryker Valuation After New Trauma Launch And Better Than Expected Earnings

Advertisement Why Stryker’s new trauma product launch matters for shareholders Stryker (SYK) is back in focus after launching its T2 Alpha Humerus Nailing Sys...

Assessing Stryker Valuation After New Trauma Launch And Better Than Expected Earnings
Simply Wall St 5d
Stryker’s New Humerus System Deepens Trauma Platform And Surgeon Ties

Stryker (NYSE:SYK) has launched the T2 Alpha Humerus Nailing System, a new trauma solution in its orthopedics portfolio. The system uses Stryker’s SOMA technol...

Stryker’s New Humerus System Deepens Trauma Platform And Surgeon Ties

Analyst ratings

78%

of 32 ratings
Buy
78.1%
Hold
18.8%
Sell
3.1%

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.